Phastar is building up its data science group as AI and machine learning ‘are rapidly modernizing clinical trials’ and Synteract boosts its centers of development in oncology and rare/orphan diseases, among other people on the move this month.
Organizations or individuals desiring change is often the reason for retirements, but the timing is often crucial and so it proved for two major institutions in the UK.
The last month of summer saw several hires, including a lead for Worldwide Clinical Trials’ Japan operations, CEO appointments at CordenPharma and LabConnect, and Altasciences’ new CSO, who joins the company from Syneos.
CordenPharma has a new CEO, Arbour Group advances plans to expand in RTP, Ashfield brings on a former Iqvia VP, and Recursion adds to its c-suite after raising $121m this month.
Newly-minted Signant Health named a new CTO, Parexel bolstered its Japan presence, and BioAgilytix’s CEO was appointed to the board of FSD Pharma – a company developing products based on cannabinoids – among other people on the move in June.
This month’s roundup includes the first CFO for CytoReason, a new CEO at Certara and Factory-CRO, as well as an expanded leadership team at BioDuro, among other people on the move in May.
Synteract adds to its therapeutic centers of development, Sterling Pharma continues growth in the US, and WCG’s site division sees the addition of several executives, among other people on the move this month.
The industry in March saw new c-suite appointments at CRF Bracket, PCI Pharma Services, George Clinical, and Paragon Bioservices – as well as moves to boost medical device and DMPK services at Premier Research and Sygnature Discovery, respectively.
Parexel boosts its oncology team, Premier Research has a new COO joining from PPD, and SGS names a new biologics manager, among other new hires in February.
A number of companies spent the early part of the year creating and then filling new positions, which has seen another big pharma company follow the trend of appointing a chief digital officer.
People on the move in January include new CEOs at Lonza, Taconic, MaSTherCell, Pii, and Wasdell, among several other c-suite shakeups and new hires as the industry kicks off the New Year.
The new year has led to a new look to executive boards across the pharma industry, but the movement has arrived with a degree of intrigue in some cases.
ABL named a successor to its previous CEO, Syneos has two new hires, and BTS Research appointed a VP to push its growth model. These, among other people on the move this month.
CROs this month have made significant new hires with WCG adding eight to its scientific leadership team, PPD hiring four, and BioIVT filling its new-created role of CCO.
Also, making the move from Bioclinica, David Kiger has been named...
The new season has brought a change in line-up for some companies with new hires and retirements, but for some it meant changing the rules to keep key players.
Metrion has bolstered its drug discovery leadership team, CluePoints has upped its RBM services, and Concept Life Sciences has added to its analytical services division, among other moves this month in the outsourced pharmaceutical services industry.
This month marked the effective start date for Parexel's new executive VP and CFO Greg Rush, who joins August's People on the Move with several other c-suite hires, including a new CEO at Citoxlab and COO at ProSciento.
In this month’s roundup, new CEO’s at Center Point Clinical Services and Clinipace Worldwide, and an equity investment in Dotmatics, which has named a new CFO.
CordenPharma has revamped its executive leadership team, Recipharm has named the head of its new global development organization, and several new CEOs have been appointed.
This month’s roundup includes a new president of commercial solutions at INC/inVentiv, a c-suite hire at UDG, and two new names at the RBM provider, CluePoints
This month’s roundup includes new CEOs at Bioclinica and Comprehend Systems, several hires at Parexel's consulting division, and new roles – and new offices – for two service providers.
This month’s round up includes Adent’s new product management director who joins the company from Eli Lily and a new CEO at Clinipace, as the CRO’s co-founder steps down after 14 years.
Novartis announces a new CEO, the MHRA re-appoints its chair, Paul Smith to lead BioAscent Discovery, and MedPharm welcomes Simon Redgrove and Jeremy Drummond.In-PharmaTechnologist catches you up on recent pharma hires.
This month’s roundup features LabCorp newly created enterprise-wide chief medical officer position and two new hires at WIRB-Copernicus Group’s eCOA arm.
Genoskin SAS collects donated human skin samples, which are kept alive in an ex vivo culture system for preclinical testing, and plans to raise €1m ($1.2m) to setup its first US-based facility.
This month’s roundup includes two new CEOs and a VP at Quanterix who will lead the company’s biomarker research, custom assay development, and clinical sample testing lab.
Ocugen welcomes ex-Pfizer Daniel Jorgensen, the IGBMA’s Biosimilars Committee gets a new chair and drug development consultants Boyds hires two associate directors in one go.
This month’s round up includes a new chief manufacturing officer at Brammer Bio and an executive hire at PPD who will help guide the CRO’s laboratory services.
The US FDA welcomes Scott Gottlieb to the helm, Actinium appoints adult leukaemia expert Richard Stone, and Bill Cheliak bring cannabinoid expertise to Tetra…
This month’s roundup includes new executive leadership teams, hires on both sides of the Atlantic for CRO Smithers Viscient, a new VP and medical director at Clinipace, among others.
Welcome to in-PharmaTechnologist's monthly round up of who's been moving where in the small-molecule manufacturing world. The CEO of BMS is moving internally, Axim Biotechnologies and Pharmalink have new board members, whilst Vium and Dova Pharmaceuticals...
From a new administration under president-elect Donald Trump, to continued consolidation, the CRO and CMO industry can expect accelerated change – good or bad – says PCI Synthesis.
